🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, efficacy, and PK of Vi...
Status
Recruiting
Location
Arkansas Childrens Hospital
Start Date
2022-10-12
Trial ID
NCT05491525
Treatments Being Tested
Radiation-induced cystitis is a condition commonly seen in patients who hav...
Status
Completed
Location
Ramathibodi Hospital
Start Date
2024-04-02
Trial ID
NCT07016451
Treatments Being Tested
The goal of this clinical trial is to compare treatment outcomes between an...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-06-06
Trial ID
NCT05806164
Treatments Being Tested
This study was a prospective, interventional, pilot clinical study conducte...
Status
Completed
Location
Kafr El-Sheikh University
Start Date
2024-07-01
Trial ID
NCT07533565
In many cases of neurogenic bladder patients, bladder compliance is lowered...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2016-01-12
Trial ID
NCT05745584
Treatments Being Tested
This study will test the hypothesis that GW427353, a beta-3 adrenergic agon...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08
Trial ID
NCT00394186
Women presenting with overactive bladder symptoms will be randomized to one...
Status
Completed
Location
Houston Methodist Hospital
Start Date
2019-08-05
Trial ID
NCT03817931
This study will assess the efficacy of vibegron compared with placebo in me...
Status
Completed
Location
Urology Centers of Alabama
Start Date
2019-03-26
Trial ID
NCT03902080
This study will assess the long-term safety of vibegron when dosed up to 52...
Status
Completed
Location
Private Practice
Start Date
2019-09-19
Trial ID
NCT04103450
Treatments Being Tested
This study will assess the efficacy of mirabegron, a new beta3-adrenergic r...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2016-09-12
Trial ID
NCT02599480